Adults 18 to 40, female only, with Contraceptive Usage or Contraception. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Current Use of Highly Effective ContraceptionPrimary· 1 month
Participants will be asked if they acquired birth control and their current use of it at 1-month period following the recruitment visit.
Did participant initiate hormonal contraception or contraceptive device at initial visit or referral? Yes/No
If yes, which contraception or contraceptive device was initiated? Implant/Depo-Provera/Birth control patch/Birth control pills/Birth control ring/Emergency contraception/ Intrauterine device
If participant started using hormonal contraception or contraceptive device at 2-week follow-up time, are they still using hormonal contraception or contracept
Group
Value
95% CI
Usual Care
2
SexHealth Mobile
17
Current Use of Highly Effective ContraceptionSecondary· 3 months
Participants will be asked if they acquired birth control and their current use of it at 2-weeks and 3-months after recruitment visit
Did participant initiate hormonal contraception or contraceptive device at initial visit or referral? Yes/No
If yes, which contraception or contraceptive device was initiated? Implant/Depo-Provera/Birth control patch/Birth control pills/Birth control ring/Emergency contraception/ Intrauterine device
If participant started using hormonal contraception or contraceptive device at 2-week follow-up time, are they still using hormonal contraception or contraceptive
Group
Value
95% CI
Usual Care
5
SexHealth Mobile
9
Sponsor's own description
Pilot study aims to evaluate the effectiveness of "SexHealth Mobile" and improve access to highly effective contraception among women with substance use disorder (SUD) with "SexHealth Mobile" intervention. This intervention will consist of two existing services that will help reach women with or recovering from SUD and provide access to contraception, as well as counseling.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
NCT07039591 — Assess Performance Attributes and Acceptability of Non-medicated Intravaginal Rings Among Sexually Active Women in Atlan
· EARLY_PHASE1
· recruiting
NCT06682065 — Telemedicine Contraceptive Counselling (TECC) Versus Standard Care
· NA
· recruiting
NCT04558229 — RCT Evaluating Standardized Counseling on Early Discontinuation for Irregular Bleeding in Nexplanon Users
· Phase 4
· active not recruiting
NCT03984695 — Sexual Health Empowerment for Women's Health
· NA
· active not recruiting
Other Children's Mercy Hospital Kansas City trials
Trials by the same sponsor.
NCT07458568 — ViBandz Feasibility Study
· not yet recruiting
NCT07195032 — Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Pediatric Heart Transplantation Patients
· Phase 4
· recruiting
NCT06834594 — Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome
· Phase 4
· recruiting
NCT06738121 — Cosmetic Outcomes of Umbilical Hernia Incisions
· NA
· completed
NCT06520657 — Addressing Social Determinants of Health in Child Obesity Treatment Using Community Health Workers
· NA
· active not recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Children's Mercy Hospital Kansas City
Last refreshed: 21 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04227145.